Aging-induced hepatocyte CD44 drives IL6/STAT3 signaling and associates with impaired neighboring T cell function.
Armin GandhiiD, Kathryn LandeiD, Kelly Yichen Li, Filipe Araujo HoffmanniD, Michael LaPorte, Shirong TaniD, K. Garrett EvenseniD, Benji Portillo, Marcos G. TenecheiD, Rouven Arnold, Adarsh RajeshiD, Jessica Proulx, Shanshan YiniD, Aaron P. HavasiD, Angela LiouiD, Allen Lee, Hélène MartiniiD, Xue LeiiD, Charlene MicianoiD, Qian Yang, Elizabeth W. SmootiD, Sainath Mamde, Andrew Davis, Rebecca A. PorrittiD, Alessandra SaccoiD, , Peter D. AdamsiD
Abstract
Liver cancer incidences increase dramatically beyond 55 years of age, suggesting that age-associated changes contribute critically to tumor initiation. However, the mechanisms linking liver aging and cancer initiation are not well defined. This study investigates the role of CD44, a marker of liver tumor-initiating cells (TIC), in age-associated liver pathophysiology. Aged livers showed accumulation of CD44-expressing hepatocytes exhibiting enrichment of immune modulatory genes and activation of the immunosuppressive IL6/JAK/STAT3 pathway. Indeed, in adoptive transfer assays, antigen-exposed CD8+ T cells mounted a lower IFN-{gamma} response in aged livers than in young livers, indicating an immunosuppressive aged milieu. Concordantly, spatial analyses showed that the proximal neighbourhoods of Cd44-expressing hepatocytes are enriched in T cells exhibiting reduced cytokine and chemokine gene expression. Finally, hepatocyte-specific knock out of Cd44 mitigated the IL6/JAK/STAT3 gene signature in aged livers. Overall, these findings suggest that CD44 expression in aged hepatocytes promotes activation of the immunosuppressive IL6/JAK/STAT3 pathway and this is associated with impaired T cell effector function.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 42%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Activated Interferon Signaling Suppresses Age-Dependent Liver Cancer
Aaron P. Havas, Kathryn Lande, … Peter D. Adams·bioRxiv·Jul 31, 2024
- CD4 T Cells Acquire Cytotoxic Properties to Modulate Cellular Senescence and Aging
Yehezqel Elyahu, Ilana Feygin, … Alon Monsonego·Nature AgingPeer-reviewed·Oct 7, 2025
- Altered composition of the γδ T cell pool in lymph nodes during ageing enhances tumour growth
Hung-Chang Chen, Nils Eling, … Maike de la Roche·bioRxiv·Nov 27, 2018
- Correction of age-associated defects in dendritic cell functions enables CD4+ T cells to eradicate tumors in the elderly
D. Zhivaki, F. Borriello, … J. C. Kagan·bioRxiv·Nov 8, 2022
- Necroptosis contributes to chronic inflammation and fibrosis in aging liver
S. Mohammed, N. Thadathil, … S. S. Deepa·bioRxiv·Sep 19, 2021
- Senescent cells induce vascular MHC II to recruit CD4+ T cells and drive inflammation in aging adipose tissue
Qijing Xie, Tzu‐Hua Lin, … Cynthia J. Kenyon·bioRxiv·May 16, 2026